NASDAQ
Quince Therapeutics, Inc. (QNCX) has a free cash flow growth of 27.26% as of Friday, May 29, 2026. This represents a 396.82% increase compared to its 12-month average of -9.18%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.